Intellia Therapeutics Inc
NASDAQ:NTLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
Multiples-Based Value
The Multiples-Based Value for
Intellia Therapeutics Inc (NTLA) under the Base Case is 11.61 USD.
Compared with the current market price of 12.35 USD, the stock appears
Overvalued by 6% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.